Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
IN: Conceptualization, Writing review & editing
Therapeutic Advances in Drug Safety, 5 (5), 190-200
CEO Albert Bourlas comment, reported this week, that Pfizer is moving beyond early development cues implies the company anticipates latestage trials, regulatory submissions and commercialization timelines that could accelerate access
Acylcarnitine profiles during carnitine loading and fasting tests in a Japanese patient with medium-chain acyl-CoA dehydrogenase deficiency
It was all about convenience back then
US$ 22.12
US$ 29.54
US$ 23.56
US$ 24.14
US$ 23.06
US$ 29.81
US$ 21.00
US$ 20.83
US$ 22.36
US$ 22.34
